Published in Infect Immun on April 01, 1996
Burkholderia cepacia produces a hemolysin that is capable of inducing apoptosis and degranulation of mammalian phagocytes. Infect Immun (1998) 1.47
A melanin pigment purified from an epidemic strain of Burkholderia cepacia attenuates monocyte respiratory burst activity by scavenging superoxide anion. Infect Immun (1999) 1.34
Efficacy of bacteriophage therapy in a model of Burkholderia cenocepacia pulmonary infection. J Infect Dis (2010) 1.29
Cable-piliated Burkholderia cepacia binds to cytokeratin 13 of epithelial cells. Infect Immun (2000) 1.20
Priming of neutrophil respiratory burst activity by lipopolysaccharide from Burkholderia cepacia. Infect Immun (1997) 1.11
Pulmonary evolution of cystic fibrosis patients colonized by Pseudomonas aeruginosa and/or Burkholderia cepacia. Eur J Pediatr (1998) 0.99
Cable pili and the 22-kilodalton adhesin are required for Burkholderia cenocepacia binding to and transmigration across the squamous epithelium. Infect Immun (2005) 0.98
Receptor mimicry as novel therapeutic treatment for biothreat agents. Bioeng Bugs (2011) 0.91
Host evasion by Burkholderia cenocepacia. Front Cell Infect Microbiol (2012) 0.82
Should patients with cystic fibrosis infected with Burkholderia cepacia undergo lung transplantation? Thorax (1997) 0.82
Linocin and OmpW Are Involved in Attachment of the Cystic Fibrosis-Associated Pathogen Burkholderia cepacia Complex to Lung Epithelial Cells and Protect Mice against Infection. Infect Immun (2016) 0.79
Electrochemical characterization of globotriose-containing self-assembled monolayers on nanoporous gold and their binding of soybean agglutinin. Carbohydr Res (2012) 0.78
Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr (1984) 9.61
Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. J Pediatr (1985) 4.26
Transmissibility of Pseudomonas cepacia infection in clinic patients and lung-transplant recipients with cystic fibrosis. N Engl J Med (1994) 3.89
Pseudomonas aeruginosa exoenzyme S: an adenosine diphosphate ribosyltransferase distinct from toxin A. Proc Natl Acad Sci U S A (1978) 3.84
Many pulmonary pathogenic bacteria bind specifically to the carbohydrate sequence GalNAc beta 1-4Gal found in some glycolipids. Proc Natl Acad Sci U S A (1988) 3.83
Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. J Biol Chem (1987) 3.71
The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain. Nat Med (1995) 3.36
Identification of the carbohydrate receptor for Shiga toxin produced by Shigella dysenteriae type 1. J Biol Chem (1987) 3.00
Pseudomonas aeruginosa pili bind to asialoGM1 which is increased on the surface of cystic fibrosis epithelial cells. J Clin Invest (1993) 3.00
Pseudomonas aeruginosa and Pseudomonas cepacia isolated from cystic fibrosis patients bind specifically to gangliotetraosylceramide (asialo GM1) and gangliotriaosylceramide (asialo GM2). Arch Biochem Biophys (1988) 2.49
Specificity of binding of a strain of uropathogenic Escherichia coli to Gal alpha 1----4Gal-containing glycosphingolipids. J Biol Chem (1985) 2.48
Crystal structure of the cell-binding B oligomer of verotoxin-1 from E. coli. Nature (1992) 2.32
Cable (cbl) type II pili of cystic fibrosis-associated Burkholderia (Pseudomonas) cepacia: nucleotide sequence of the cblA major subunit pilin gene and novel morphology of the assembled appendage fibers. J Bacteriol (1995) 2.16
Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway diseases. Am J Physiol (1993) 2.14
Quantitative determination of the neutral glycosyl ceramides in human blood. J Lipid Res (1967) 2.04
Sputum tumour necrosis factor-alpha and leukotriene concentrations in cystic fibrosis. Arch Dis Child (1993) 1.94
Binding of Pseudomonas cepacia to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis. J Clin Invest (1992) 1.80
Carbohydrate-specific adhesion of bacteria to thin-layer chromatograms: a rationalized approach to the study of host cell glycolipid receptors. Anal Biochem (1985) 1.78
Gastric glycerolipid as a receptor for Campylobacter pylori. Lancet (1989) 1.72
Purification and characterization of an extracellular protease from Pseudomonas cepacia. Infect Immun (1989) 1.70
Saccharide orientation at the cell surface affects glycolipid receptor function. Proc Natl Acad Sci U S A (1991) 1.69
Alteration of the carbohydrate binding specificity of verotoxins from Gal alpha 1-4Gal to GalNAc beta 1-3Gal alpha 1-4Gal and vice versa by site-directed mutagenesis of the binding subunit. Proc Natl Acad Sci U S A (1992) 1.43
Binding of verocytotoxin 1 to its receptor is influenced by differences in receptor fatty acid content. Biochemistry (1992) 1.36
Identification of the mucin-binding adhesin of Pseudomonas cepacia isolated from patients with cystic fibrosis. Infect Immun (1992) 1.35
Shiga toxin-associated hemolytic uremic syndrome: interleukin-1 beta enhancement of Shiga toxin cytotoxicity toward human vascular endothelial cells in vitro. Infect Immun (1993) 1.31
Isolation of a novel siderophore from Pseudomonas cepacia. J Med Microbiol (1992) 1.27
Pseudomonas cepacia adherence to respiratory epithelial cells is enhanced by Pseudomonas aeruginosa. Infect Immun (1990) 1.27
Production of lipase by clinical isolates of Pseudomonas cepacia. J Clin Microbiol (1988) 1.25
Helicobacter mustelae and Helicobacter pylori bind to common lipid receptors in vitro. Infect Immun (1993) 1.25
Structurally variant classes of pilus appendage fibers coexpressed from Burkholderia (Pseudomonas) cepacia. J Bacteriol (1995) 1.24
The glycerolipid receptor for Helicobacter pylori (and exoenzyme S) is phosphatidylethanolamine. Infect Immun (1992) 1.22
Role of a 22-kilodalton pilin protein in binding of Pseudomonas cepacia to buccal epithelial cells. Infect Immun (1993) 1.19
Possible role of ceramide in defining structure and function of membrane glycolipids. Proc Natl Acad Sci U S A (1982) 1.09
Polyisobutylmethacrylate modifies glycolipid binding specificity of verotoxin 1 in thin-layer chromatogram overlay procedures. Anal Biochem (1992) 1.07
Microbial interaction with animal cell surface carbohydrates. APMIS Suppl (1992) 1.07
Chlamydia trachomatis and Chlamydia pneumoniae bind specifically to phosphatidylethanolamine in HeLa cells and to GalNAc beta 1-4Gal beta 1-4GLC sequences-found in asialo-GM1 and asial-GM2. Biochem Biophys Res Commun (1991) 1.00
Fimbriation of Pseudomonas cepacia. Infect Immun (1992) 0.96
Lacto- and ganglio-series glycolipids are adhesion receptors for Neisseria gonorrhoeae. J Biol Chem (1990) 0.92
Glycolipid receptor binding specificity of exoenzyme S from Pseudomonas aeruginosa. Biochem Biophys Res Commun (1991) 0.90
Model membranes bearing glycolipids and glycoproteins. Chem Phys Lipids (1986) 0.77
Cable (cbl) type II pili of cystic fibrosis-associated Burkholderia (Pseudomonas) cepacia: nucleotide sequence of the cblA major subunit pilin gene and novel morphology of the assembled appendage fibers. J Bacteriol (1995) 2.16
Intestinal mucins in health and disease. Digestion (1978) 1.94
Binding of Pseudomonas cepacia to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis. J Clin Invest (1992) 1.80
Goblet cell mucin of rat small intestine. Chemical and physical characterization. Can J Biochem (1973) 1.55
Antigenic and structural features of goblet-cell mucin of human small intestine. Biochem J (1984) 1.48
Heterogeneity of rat goblet-cell mucin before and after reduction. Biochem J (1983) 1.42
Biochemical characterization of the component parts of intestinal mucin from patients with cystic fibrosis. Biochem J (1984) 1.40
Identification of the mucin-binding adhesin of Pseudomonas cepacia isolated from patients with cystic fibrosis. Infect Immun (1992) 1.35
The putative 'link' glycopeptide associated with mucus glycoproteins. Composition and properties of preparations from the gastrointestinal tracts of several mammals. Biochem J (1989) 1.33
Vibrio cholerae metalloproteinase degrades intestinal mucin and facilitates enterotoxin-induced secretion from rat intestine. Biochim Biophys Acta (1987) 1.33
cDNA for the carboxyl-terminal region of a rat intestinal mucin-like peptide. J Biol Chem (1992) 1.28
Characteristics of binding of Escherichia coli serotype O157:H7 strain CL-49 to purified intestinal mucin. Infect Immun (1990) 1.28
Radioimmunoassay of human intestinal goblet cell mucin. Investigation of mucus from different organs and species. J Clin Invest (1979) 1.24
Structurally variant classes of pilus appendage fibers coexpressed from Burkholderia (Pseudomonas) cepacia. J Bacteriol (1995) 1.24
Characterization and localization of the putative 'link' component in rat small-intestinal mucin. Biochem J (1987) 1.20
Cable-piliated Burkholderia cepacia binds to cytokeratin 13 of epithelial cells. Infect Immun (2000) 1.20
Role of a 22-kilodalton pilin protein in binding of Pseudomonas cepacia to buccal epithelial cells. Infect Immun (1993) 1.19
Enhancement of the viscosity of mucin by serum albumin. Biochem J (1978) 1.14
The T84 human colonic adenocarcinoma cell line produces mucin in culture and releases it in response to various secretagogues. Biochem J (1990) 1.08
P-113D, an antimicrobial peptide active against Pseudomonas aeruginosa, retains activity in the presence of sputum from cystic fibrosis patients. Antimicrob Agents Chemother (2001) 1.08
The role of disulphide bonds in human intestinal mucin. Biochem J (1979) 1.05
Human intestinal mucin-like protein (MLP) is homologous with rat MLP in the C-terminal region, and is encoded by a gene on chromosome 11 p 15.5. Biochem Biophys Res Commun (1992) 1.02
Effects of calcium on intestinal mucin: implications for cystic fibrosis. Pediatr Res (1976) 1.01
Synthesis and secretion of mucin by the human colonic tumour cell line LS180. Biochem J (1994) 1.01
Intestinal mucins inhibit rotavirus replication in an oligosaccharide-dependent manner. J Infect Dis (1994) 0.99
Cholera toxin stimulates secretion of immunoreactive intestinal mucin. Am J Physiol (1981) 0.98
Calcium binding to intestinal goblet cell mucin. Biochim Biophys Acta (1975) 0.96
Evidence that a peptide corresponding to the rat Muc2 C-terminus undergoes disulphide-mediated dimerization. Eur J Biochem (1998) 0.96
Radioimmunoassay of intestinal goblet cell mucin. Anal Biochem (1977) 0.95
Role of the putative "link" glycopeptide of intestinal mucin in binding of piliated Escherichia coli serotype O157:H7 strain CL-49. Infect Immun (1990) 0.93
Proteinaceous factor(s) in culture supernatant fluids of bifidobacteria which prevents the binding of enterotoxigenic Escherichia coli to gangliotetraosylceramide. Appl Environ Microbiol (1997) 0.92
The carboxyl-terminal sequence of rat intestinal mucin RMuc3 contains a putative transmembrane region and two EGF-like motifs. Biochim Biophys Acta (1997) 0.91
Adherence to lipids and intestinal mucin by a recently recognized human pathogen, Campylobacter upsaliensis. Infect Immun (1996) 0.91
Role of the cystine-knot motif at the C-terminus of rat mucin protein Muc2 in dimer formation and secretion. Biochem J (2001) 0.88
Susceptibility of the cysteine-rich N-terminal and C-terminal ends of rat intestinal mucin muc 2 to proteolytic cleavage. Biochem J (1998) 0.86
Regulated and unregulated pathways for MUC2 mucin secretion in human colonic LS180 adenocarcinoma cells are distinct. Biochem J (1995) 0.86
Protein kinase C-epsilon is the likely mediator of mucin exocytosis in human colonic cell lines. Am J Physiol (1997) 0.85
Characteristics of rodent intestinal mucin Muc3 and alterations in a mouse model of human cystic fibrosis. Am J Physiol Gastrointest Liver Physiol (2001) 0.85
The effects of delipidation on the major antigenic determinant of purified human intestinal mucin. Biochem Cell Biol (1986) 0.85
Structural and compositional differences between intracellular and secreted mucin of rat small intestine. Biochem J (1987) 0.85
Suggestive evidence for two different mucin genes in rat intestine. Biochem J (1993) 0.84
Purification and characterization of a novel protein produced by Bifidobacterium longum SBT2928 that inhibits the binding of enterotoxigenic Escherichia coli Pb176 (CFA/II) to gangliotetraosylceramide. J Appl Microbiol (1999) 0.83
Radiation inactivation of human intestinal mucin: determination of the size of the functional antigenic unit. Biochim Biophys Acta (1986) 0.83
The cationic C-terminus of rat Muc2 facilitates dimer formation post translationally and is subsequently removed by furin. Eur J Biochem (2000) 0.83
Epithelial response to intestinal anaphylaxis in rats: goblet cell secretion and enterocyte damage. Am J Physiol (1984) 0.83
Roles of calreticulin and calnexin during mucin synthesis in LS180 and HT29/A1 human colonic adenocarcinoma cells. Biochem J (1999) 0.82
Interaction of mucins with calcium, H+ ion and albumin. Mod Probl Paediatr (1978) 0.82
Structure of intestinal-mucus glycoprotein from human post-mortem or surgical tissue: inferences from correlation analyses of sugar and sulfate composition of individual mucins. Carbohydr Res (1983) 0.80
Tissue-specific expression of a rat intestinal mucin-like peptide. Biochem J (1992) 0.79
Factors affecting the synthesis of 2,3-diphosphoglycerate in hemolysates of human erythrocytes. Biochim Biophys Acta (1968) 0.78
Cloning of the cDNA for a rat intestinal Na+/dicarboxylate cotransporter reveals partial sequence homology with a rat intestinal mucin. Biochim Biophys Acta (1996) 0.78
Differences in mucus glycoproteins of small intestine from subjects with and without cystic fibrosis. Adv Exp Med Biol (1982) 0.78
Stimulation of proteolytic digestion by intestinal goblet cell mucus. Gastroenterology (1975) 0.77
Purification and immunofluorescent localization of rat submandibular mucin. Biochem J (1982) 0.75
Radioimmunoassay of rat submandibular salivary gland mucin. Arch Oral Biol (1983) 0.75
Mucin domains to explore disulfide-dependent dimer formation. Methods Mol Biol (2000) 0.75
The use of radioimmunoassay as a probe of the antigenic determinants and structure of human small intestinal mucin. Adv Exp Med Biol (1982) 0.75
Interaction of heparin with synthetic peptides corresponding to the C-terminal domain of intestinal mucins. Glycoconj J (1996) 0.75